Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/14/2023 | OmniAb, Inc. | | Purchase | Common Stock | 45k | $5.48 | $246.6k | | 08/14/2023 |
06/09/2023 | OmniAb, Inc. | | Purchase | Common Stock | 115k | $4.52 | $519.8k | | 06/09/2023 |
01/03/2023 | Viking Therapeutics, Inc. | VKTX | Grant | Stock Option (Right to Buy) | 22k | $8.52 | $187.4k | | 01/03/2023 |
01/03/2023 | OmniAb, Inc. | | Grant | Common Stock | 79.7k | $0.00 | $0 | | 01/03/2023 |
12/28/2022 | OmniAb, Inc. | | Payment of Exercise | Common Stock | 11.6k | $3.66 | $42.5k | | 12/28/2022 |
12/12/2022 | OmniAb, Inc. | | Purchase | Common Stock | 150k | $3.77 | $564.8k | | 12/12/2022 |
12/07/2022 | OmniAb, Inc. | | Grant | Stock Option | 298.3k | $3.68 | $1.1M | | 12/07/2022 |
12/01/2022 | OmniAb, Inc. | | Payment of Exercise | Common Stock | 17.3k | $3.35 | $57.8k | | 12/01/2022 |
11/30/2022 | OmniAb, Inc. | | Purchase | Common Stock | 300k | $3.39 | $1M | | 11/30/2022 |
11/09/2022 | OmniAb, Inc. | | Purchase | Common Stock | 100k | $2.76 | $276.2k | | 11/09/2022 |
06/10/2022 | LIGAND PHARMACEUTICALS INC | LGND | Grant | Common Stock | 9.1k | $0.00 | $0 | | 06/10/2022 |
05/13/2022 | LIGAND PHARMACEUTICALS INC | LGND | Purchase | Common Stock | 2.5k | $82.76 | $206.9k | | 05/13/2022 |
05/05/2022 | LIGAND PHARMACEUTICALS INC | LGND | Grant | Employee Stock Option (right to buy) | 34.2k | $90.68 | $3.1M | | 05/05/2022 |
05/02/2022 | Viking Therapeutics, Inc. | VKTX | Purchase | Common Stock, par value $0.00001 per share | 45k | $2.47 | $111.2k | | 05/02/2022 |
02/15/2022 | LIGAND PHARMACEUTICALS INC | LGND | Payment of Exercise | Common Stock | 1.2k | $123.68 | $152.6k | | 02/15/2022 |
02/15/2022 | LIGAND PHARMACEUTICALS INC | LGND | Payment of Exercise | Common Stock | 1.2k | $123.68 | $151.1k | | 02/15/2022 |
02/15/2022 | LIGAND PHARMACEUTICALS INC | LGND | Payment of Exercise | Common Stock | 1.1k | $123.68 | $134.8k | | 02/15/2022 |
01/26/2022 | LIGAND PHARMACEUTICALS INC | LGND | Grant | Common Stock | 5.6k | $0.00 | $0 | | 01/26/2022 |
01/26/2022 | LIGAND PHARMACEUTICALS INC | LGND | Grant | Common Stock | 7.4k | $0.00 | $0 | | 01/26/2022 |
01/26/2022 | LIGAND PHARMACEUTICALS INC | LGND | Payment of Exercise | Common Stock | 1.9k | $113.68 | $220.2k | | 01/26/2022 |
01/26/2022 | LIGAND PHARMACEUTICALS INC | LGND | Payment of Exercise | Common Stock | 3.2k | $113.68 | $362.4k | | 01/26/2022 |
01/03/2022 | Viking Therapeutics, Inc. | VKTX | Grant | Stock Option (Right to Buy) | 22k | $4.88 | $107.4k | | 01/03/2022 |
11/11/2021 | LIGAND PHARMACEUTICALS INC | LGND | Sale | Common Stock | 11.2k | $163.02 | $1.8M | | 11/11/2021 |
11/11/2021 | LIGAND PHARMACEUTICALS INC | LGND | Exercise | Employee Stock Option (right to buy) | 11.2k | $21.92 | $244.6k | | 11/11/2021 |
11/11/2021 | LIGAND PHARMACEUTICALS INC | LGND | Exercise | Employee Stock Option (right to buy) | 1k | $100.38 | $103.2k | | 11/11/2021 |
08/04/2021 | LIGAND PHARMACEUTICALS INC | LGND | Sale | Common Stock | 8.8k | $109.67 | $969.5k | | 08/04/2021 |
08/04/2021 | LIGAND PHARMACEUTICALS INC | LGND | Exercise | Employee Stock Option (right to buy) | 8.8k | $21.92 | $193.8k | | 08/04/2021 |
08/04/2021 | LIGAND PHARMACEUTICALS INC | LGND | Exercise | Employee Stock Option (right to buy) | 1.1k | $85.79 | $98k | | 08/04/2021 |
06/10/2021 | Viking Therapeutics, Inc. | VKTX | Purchase | Common Stock, par value $0.00001 per share | 20k | $5.69 | $113.8k | | 06/10/2021 |
05/28/2021 | LIGAND PHARMACEUTICALS INC | LGND | Exercise | Employee Stock Option (right to buy) | 1.8k | $56.26 | $98.7k | | 05/28/2021 |
05/28/2021 | LIGAND PHARMACEUTICALS INC | LGND | Gift | Common Stock | 2.5k | $0.00 | $0 | | 05/28/2021 |
03/22/2021 | Viking Therapeutics, Inc. | VKTX | Exercise (in-the-money or at-the-money) | Warrants (Right to Buy) | 20k | $1.50 | $30k | | 03/22/2021 |
02/15/2021 | LIGAND PHARMACEUTICALS INC | LGND | Payment of Exercise | Common Stock | 641 | $172.46 | $110.5k | | 02/15/2021 |
02/15/2021 | LIGAND PHARMACEUTICALS INC | LGND | Payment of Exercise | Common Stock | 1.2k | $172.46 | $213k | | 02/15/2021 |
02/15/2021 | LIGAND PHARMACEUTICALS INC | LGND | Payment of Exercise | Common Stock | 1.2k | $172.46 | $210.7k | | 02/15/2021 |
|